Concurrent Palliative Chemoradiotherapy versus Definitive Chemoradiotherapy in Poor Prognosis Stage III non-small-cell lung cancer
Maha Abd-El Hady El-Khafif;
Abstract
Abstract
Background: The palliative role of chemoradiation in treatment of patients with locally advanced non-small-cell lung cancer remains unresolved; Controversy remains about whether long term and high doses radiotherapy provide better results than short course schedules in treatment of inoperable stage III NSCLC and negative prognostic factors poor performance status (PS), large tumor, poor pulmonary functions and comorbidities.Hypofractionated radiotherapy can expose tumors to a high dose of radiation in a short period of time.
Background: The palliative role of chemoradiation in treatment of patients with locally advanced non-small-cell lung cancer remains unresolved; Controversy remains about whether long term and high doses radiotherapy provide better results than short course schedules in treatment of inoperable stage III NSCLC and negative prognostic factors poor performance status (PS), large tumor, poor pulmonary functions and comorbidities.Hypofractionated radiotherapy can expose tumors to a high dose of radiation in a short period of time.
Other data
| Title | Concurrent Palliative Chemoradiotherapy versus Definitive Chemoradiotherapy in Poor Prognosis Stage III non-small-cell lung cancer | Other Titles | العلاج الكيمائى مع الاشعاعي التلطيفى ازاء العلاج الكيمائى مع الاشعاعى التقليدي في علاج المراحل المتقدمة من سرطان الرئة | Authors | Maha Abd-El Hady El-Khafif | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.